These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20717628)

  • 21. Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN.
    de Parseval A; Su SV; Elder JH; Lee B
    J Virol; 2004 Mar; 78(5):2597-600. PubMed ID: 14963164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-Valent Calix[4]arene Glycoconjugates Based on Hydroxamic Acid Bearing Linkers as Potent Inhibitors in a Model of Ebola Virus Cis-Infection and HCMV-gB-Recombinant Glycoprotein Interaction with MDDC Cells by Blocking DC-SIGN.
    Chakroun K; Taouai M; Porkolab V; Luczkowiak J; Sommer R; Cheneau C; Mathiron D; Ben Maaouia MA; Pilard S; Abidi R; Mullié C; Fieschi F; Cragg PJ; Halary F; Delgado R; Benazza M
    J Med Chem; 2021 Oct; 64(19):14332-14343. PubMed ID: 34524803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate mimics and lectins: a source of new drugs and therapeutic opportunities.
    Reina JJ; Bernardi A
    Mini Rev Med Chem; 2012 Dec; 12(14):1434-42. PubMed ID: 22827173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonists.
    Bertolotti B; Sutkeviciute I; Ambrosini M; Ribeiro-Viana R; Rojo J; Fieschi F; Dvořáková H; Kašáková M; Parkan K; Hlaváčková M; Nováková K; Moravcová J
    Org Biomol Chem; 2017 May; 15(18):3995-4004. PubMed ID: 28443908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of DC-SIGN in human foreskin may facilitate sexual transmission of HIV.
    Soilleux EJ; Coleman N
    J Clin Pathol; 2004 Jan; 57(1):77-8. PubMed ID: 14693841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Remote Secondary Binding Pocket Promotes Heteromultivalent Targeting of DC-SIGN.
    Wawrzinek R; Wamhoff EC; Lefebre J; Rentzsch M; Bachem G; Domeniconi G; Schulze J; Fuchsberger FF; Zhang H; Modenutti C; Schnirch L; Marti MA; Schwardt O; Bräutigam M; Guberman M; Hauck D; Seeberger PH; Seitz O; Titz A; Ernst B; Rademacher C
    J Am Chem Soc; 2021 Nov; 143(45):18977-18988. PubMed ID: 34748320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2.
    Cramer J; Lakkaichi A; Aliu B; Jakob RP; Klein S; Cattaneo I; Jiang X; Rabbani S; Schwardt O; Zimmer G; Ciancaglini M; Abreu Mota T; Maier T; Ernst B
    J Am Chem Soc; 2021 Oct; 143(42):17465-17478. PubMed ID: 34652144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists.
    Obermajer N; Sattin S; Colombo C; Bruno M; Svajger U; Anderluh M; Bernardi A
    Mol Divers; 2011 May; 15(2):347-60. PubMed ID: 21076980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses.
    Navarro-Sanchez E; Altmeyer R; Amara A; Schwartz O; Fieschi F; Virelizier JL; Arenzana-Seisdedos F; Desprès P
    EMBO Rep; 2003 Jul; 4(7):723-8. PubMed ID: 12783086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly-l-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses.
    Cramer J; Aliu B; Jiang X; Sharpe T; Pang L; Hadorn A; Rabbani S; Ernst B
    ChemMedChem; 2021 Aug; 16(15):2345-2353. PubMed ID: 34061468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN).
    Chung NP; Breun SK; Bashirova A; Baumann JG; Martin TD; Karamchandani JM; Rausch JW; Le Grice SF; Wu L; Carrington M; Kewalramani VN
    J Biol Chem; 2010 Jan; 285(3):2100-12. PubMed ID: 19833723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanions.
    Auwerx J; François KO; Vanstreels E; Van Laethem K; Daelemans D; Schols D; Balzarini J
    Antiviral Res; 2009 Jul; 83(1):61-70. PubMed ID: 19514109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells.
    Arrighi JF; Pion M; Garcia E; Escola JM; van Kooyk Y; Geijtenbeek TB; Piguet V
    J Exp Med; 2004 Nov; 200(10):1279-88. PubMed ID: 15545354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
    Martínez-Avila O; Hijazi K; Marradi M; Clavel C; Campion C; Kelly C; Penadés S
    Chemistry; 2009 Sep; 15(38):9874-88. PubMed ID: 19681073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of DC-SIGN
    Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting Multivalent Lectin-Carbohydrate Recognition Using Polyvalent Multifunctional Glycan-Quantum Dots.
    Guo Y; Nehlmeier I; Poole E; Sakonsinsiri C; Hondow N; Brown A; Li Q; Li S; Whitworth J; Li Z; Yu A; Brydson R; Turnbull WB; Pöhlmann S; Zhou D
    J Am Chem Soc; 2017 Aug; 139(34):11833-11844. PubMed ID: 28786666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
    Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
    J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.
    Spear GT; Zariffard MR; Xin J; Saifuddin M
    Immunology; 2003 Sep; 110(1):80-5. PubMed ID: 12941144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN.
    Trumpfheller C; Park CG; Finke J; Steinman RM; Granelli-Piperno A
    Int Immunol; 2003 Feb; 15(2):289-98. PubMed ID: 12578859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymeric anti-HIV therapeutics.
    Danial M; Klok HA
    Macromol Biosci; 2015 Jan; 15(1):9-35. PubMed ID: 25185484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.